Kindstar Globalgene Technology (KINDSTAR GLOBAL) reported a minor adjustment to its share capital following a repurchase executed on 1 September 2026 under its Hong Kong listing mandate.

The company bought back 14,000 ordinary shares on the Hong Kong Stock Exchange at prices between HKD 0.98 and HKD 1.00, spending a total of HKD 13,878.20. The repurchased stock will be held as treasury shares.

Post-transaction, issued shares excluding treasury stock fell 0.00174 % to 1,032.65 million, while treasury shares rose to 8.68 million. Total issued shares remained unchanged at 1,041.33 million.

Since shareholders approved the current repurchase mandate on 5 June 2026, KINDSTAR GLOBAL has acquired 1.61 million shares, equal to 0.16 % of the share count outstanding on the mandate date. The company is authorised to repurchase up to 103.43 million shares. In line with Hong Kong listing rules, KINDSTAR GLOBAL is subject to a moratorium on issuing new shares or selling treasury shares until 1 October 2026.